The impact of glucose absorbed from dialysis solution on body weight gain in peritoneal dialysis treated patients;Utjecaj glukoze apsorbirane iz dijalizata na tjelesnu težinu peritonejskom dijalizom liječenih bolesnika

Lijecnicki Vjesnik

Volumn 127, Issue 5-6, 2005, Pages 116-120

  Jakić, Marko ^a,e   Stipanić, Sanja ^a   Mihaljević, Dubravka ^a   Zibar, Lada ^a   Lovčić, Vesna ^b   Klarić, Dragan ^c   Jakić, Marijana ^d  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^b Op a Bolnica Bjelovar   (Croatia)

^c OP A BOLNICA ZADAR   (Croatia)

^d Zavod za Javno Zdravstvo Osje ko Baranjske upanije   (Croatia)

^e NONE   (Croatia)

Author keywords

Body weight; Glucose metabolism; Kidney failure, chronic therapy; Peritoneal dialysis

Indexed keywords

CREATININE; DIALYSIS FLUID; GLUCOSE; MITOCHONDRIAL PROTEIN; REGULATOR PROTEIN; UNCOUPLING PROTEIN; UREA;

ADULT; ARTICLE; BLOOD; BODY WEIGHT; CALORIE; CLINICAL ARTICLE; DIALYSATE; FEMALE; FLUID RETENTION; GENETIC POLYMORPHISM; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; HUMAN; KIDNEY FAILURE; LIPID STORAGE; MALE; OSMOLALITY; PERITONEAL DIALYSIS; PHENOTYPE; SEX DIFFERENCE; WEIGHT GAIN;

EID: 29844446119     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Heimburger O, Lonnquist F, Danielsson A, Nordenstrom J, Stenvinkel P. Serum immunoreactive leptin concentration and its relation to body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-30.
2. Johansson AC, Samuelsson O, Haraldsson B, Bosaeus J, Attman PO. Body composition in patients treated with peritoneal dialysis. Nephrol Dial Transplant 1998;13:1511-7.
3. Bazzato G, Scanferla F, Landini S i sur. Bioimpedance: a new tool to assess nutritional status. Longitudinal study in peritoneal vs. hemodialysis patients. U: Ota K, Maher JF, Winchester JF, Hirszel P, Ito K, Suzuki T, ur. Current concepts in peritoneal dialysis. Amsterdam: Excerpta Medica; 1992, str. 516-522.
4. Jager KJ, Merkus MP, Huisman RM i sur. Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001;12:1272-9.
5. Stenvinkel P, Lindholm B, Lonnquist F, Katzarski KOH. Increase in serum leptin during peritoneal dialysis are associated with inflammation and a descrease in lean body mass. J Am Soc Nephrol 2000;11:1303-9.
6. Tranœus A, Heimburger O, Lindholm B, Bergstrom J. Six years' experience of CAPD at one centre: A survey of major findings. Perit Dial Int 1988;8:31-41.
7. Viglino G, Galio M, Cottino R i sur. Assessment of nutritional status of CAPD patients during 5-years follow-up, U: Ota K, Maher JF, Winchester JF, Hirszel P, Ito K, Suzuki T, ur. Current concepts in peritoneal dialysis. Amsterdam: Excerpta Medica; 1992, str. 497-505.
8. Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG. Excessive weight gain during peritoneal dialysis. Int J Artif Organ 2001;24:197-202.
9. Boeschoten EW, Zuyderhoudt FMJ, Krediet RT, Arisz L. Changes in weight and lipid concentrations during CAPD treatment. Pent Dial Int 1988;8:19-24.
10. Heimburger O. Obesity on PD patients: Causes and management. In: Ronco C, Dell' Aquilla R, Rodighiero MP. Peritoneal dialysis today. Contributions to Nephrology. Editor: Ronco C. Karger Basel-Freiburg-Paris-London-New York-Bangalore-Bangkok-Singapore-Tokyo-Sydney. 2003;91-97.
11. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992;41:1320-32.
12. Nordfors L, Heimburger O, Lonnquist F i sur. Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 2000;57:1713-9.
13. Davies SJ, Russel L, Bryan J, Phillips L, Russel GI. Impact of peritoneal absorption of glucose on appetite, protein catabolism and survival in CAPD patients. Clin Nephrol 1996;45:194-8.
14. Bigardus C, Lillioja S, Ravussin E i sur. Familial dependence of the resting metabolic rate. N Engl J Med 1986;315:96-100.
15. Bouchard C, Tremblay A, Nadeau A i sur. Genetic effects in resting and exercise metabolic rates. Metabolism 1989;38:364-70.
16. Walder K, Norman RA, Hanson RL i sur. Association between uncoupling protein polymorphism (UCP2-UCP3) and energy expenditure/obesity in Pima Indians. Hum Mol Genet 1998;7:1431-5.
17. Stunkard AJ, Harris JR, Pederson NL, McClearn GE. The body-mass index in twins who have been reared apart. N Engl J Med 1990;322:1483-7.
18. Astrup A, Bulow J, Madsen J, Christensen NJ. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol 1985;248:E507-E515.
19. Fleury C, Neverova M, Collins SH i sur. Uncoupling protein-2: A novel gene link to obesity and hyperinsulinemia. Nat Genet 1997;15:269-72.
20. Boss O, Samec S, Paolino-Giacobino A i sur. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997;408:39-42.
21. Schrauwen P, Walder K, Ravussin E. Human uncoupling proteins and obesity. Obes Res 1999;7:97-105.
22. Lamont S. Beta-blockers and their effects on protein metabolism and resting energy expenditure. J Cardiopulm Rehabil 1995;15:183-5.
23. Salahudeen AK. It is really good to be fat on dialysis? Nephrol Dial Transplant 2003;18:1248-52.
24. Kelner K, Helmuth L. Obesity - What is to be done? Science 2003;299:845-8.
25. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999;55:1560-7.
26. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight for height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999;56:1136-48.
27. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in »healthier« as compare with »sicker« hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001;16:2386-94.
28. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002;13:1061-6.
29. Degoulet P, Legrain M, Reach I i sur. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982;31:103-10.
30. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 2000;35:80-8.
31. Kaizu Y, Tsunega Y, Yoneyama T i sur. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol 1998;50:44-50.
32. Combe C, Chauveau P, Laville M i sur. Influence of nutritional factors and hemodialysis adequacy on the survival of 1610 French patients. Am J Kidney Dis 2001;37:S81-S88.
33. Marcen R, Teruel JL, de la Cal MA, Gamez C. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. Nephrol Dial Transplant 1997;12:2324-31.
34. Johnson DW, Herzig KA, Purdie DM i sur. Is obesity a favorable prognostic factor in peritoneal dialysis patients? Pent Dial Int 2000;20(6):715-21.
35. Abbott KC, Glanton CW, Trespalacios FC i sur. Body mass index, dialysis modality, and survival: Analysis of the United States Renal Data System Dialysis morbidity and mortality wave II study. Kidney Int 2004;65 (2):597-605.
36. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populatins. J Am Soc Nephrol 2003;14(11):2894-901.
37. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003;64(5):1838-44.
38. Denke M, Wilson JD. Assessment of nutritional status. U: Fauci AS, Braunwald E, Isselbacher KJ, ur. Harrison's principles of internal medicine. New York-London-Toronto. McGrawHill: 1998;448-52.
39. Twardowski ZJ, Nolph KD, Khanna R i sur. Peritoneal equilibration test. Pent Dial Bull 1987;7:138-47.
40. Božikov J, Ivanković D, Kern J, Kopjar B, Luković G, Vuletić S. Osnove statističke analize za medicinare. Zagreb: Medicinski fakultet Sveučilišta u Zagrebu; 1991.
41. Yanowski JA, Yanowski SZ. Recent advances in basic obesity research. JAMA 1999;282:1504-6.
42. Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue - a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002;17:191-5.
43. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001;60:329-39.
44. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxyphilline. Med Hypotheses 1999;52:465-77.
45. Festa A, D'Agostino R, Williams K i sur. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-15.
46. Stompor T, Sulowicz W, Dembinska-Kieć A, Janda K, Wüjcik K, Zdzienicka J. An association between body mass index and markers of inflammation: Is obesity the proinflammatory state in patients on peritoneal dialysis? Perit Dial Int 2003;23(1):79-83.
47. Tzamaloukas AH, Murata GH, Servilla KS, Hoffman RM. Weight deficit in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2002;39(5):1068-77.